MiMedx Group, Inc. (MDXG)
3.21
-0.03
(-0.93%)
USD |
NASDAQ |
Nov 13, 16:00
3.20
-0.01
(-0.31%)
After-Hours: 19:59
MiMedx Group Market Cap : 468.42M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 468.42M |
| November 12, 2026 | 472.80M |
| November 11, 2026 | 484.47M |
| November 10, 2026 | 491.77M |
| November 09, 2026 | 484.47M |
| November 06, 2026 | 483.01M |
| November 05, 2026 | 478.64M |
| November 04, 2026 | 466.96M |
| November 03, 2026 | 474.26M |
| November 02, 2026 | 478.64M |
| October 30, 2026 | 566.19M |
| October 29, 2026 | 579.32M |
| October 28, 2026 | 576.41M |
| October 27, 2026 | 569.11M |
| October 26, 2026 | 561.81M |
| October 23, 2026 | 569.78M |
| October 22, 2026 | 572.70M |
| October 21, 2026 | 545.01M |
| October 20, 2026 | 616.41M |
| October 19, 2026 | 638.27M |
| October 16, 2026 | 645.56M |
| October 15, 2026 | 681.99M |
| October 14, 2026 | 684.90M |
| October 13, 2026 | 683.45M |
| October 12, 2026 | 703.85M |
| Date | Value |
|---|---|
| October 09, 2026 | 680.53M |
| October 08, 2026 | 673.25M |
| October 07, 2026 | 671.79M |
| October 06, 2026 | 673.25M |
| October 05, 2026 | 663.05M |
| October 02, 2026 | 668.88M |
| October 01, 2026 | 676.16M |
| September 30, 2026 | 679.08M |
| September 29, 2026 | 680.53M |
| September 28, 2026 | 681.99M |
| September 25, 2026 | 680.53M |
| September 24, 2026 | 686.36M |
| September 23, 2026 | 695.11M |
| September 22, 2026 | 718.42M |
| September 21, 2026 | 700.93M |
| September 18, 2026 | 695.11M |
| September 17, 2026 | 683.45M |
| September 16, 2026 | 689.28M |
| September 15, 2026 | 687.82M |
| September 14, 2026 | 676.16M |
| September 11, 2026 | 665.96M |
| September 10, 2026 | 670.33M |
| September 09, 2026 | 681.99M |
| September 08, 2026 | 680.53M |
| September 04, 2026 | 665.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 179.48M |
| Perspective Therapeutics, Inc. | 107.67M |
| T2 Biosystems, Inc. | 0.1876M |
| ABVC BioPharma, Inc. | 24.43M |
| Enovis Corp. | 1.597B |
Market Cap Related Metrics
| PS Ratio | 1.565 |
| Price to Book Value | 2.219 |
| Price to Free Cash Flow | 28.31 |
| Price | 3.21 |
| Earnings Yield | -4.11% |